Yu Fang

Dr. Yu Fang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology
Verified
Journal Article
Closed access
LZLang Zhang
Lang Zhang
YFYu Fang
Yu Fang
XLXing Lu
Xing Lu
SXShanshan Xu
Shanshan Xu
FCFangfang Cai
Fangfang Cai
SZShan Zhong
Shan Zhong

23 December 2021 in Genes
Verified
Journal Article
Open access
PDF file
XZXinyang Zhang
Xinyang Zhang
YSYang Siqi
Yang Siqi
CWChen Wenbo
Chen Wenbo
XDXin Dong
Xin Dong
RZRongyu Zhang
Rongyu Zhang
CHChunjiang He
Chunjiang He
Cervical cancer (CC) is one of the most threatening diseases in women. Circular RNAs (circRNAs) have been reported to be cancer hallmarks, but typical circRNAs in CC were rarely indicated. Through high-throughput sequencing in CC and normal cervix tissues, circYPEL2 (hsa_circ_0005600) was proposed as a candidate circRNA. CircYPEL2 exhibited significantly high expression in CC tissue and strong stability in CC cell lines. Furthermore, knockdown and overexpression of circYPEL2 indicated the potential involvement in CC proliferation, migration and invasion. Finally, the downstream regulatory genes of circYPEL2 were investigated by knockdown experiment in CC cell lines with high-throughput sequencing. In summary, our work identified circYPEL2 as a potential biomarker for clinical research of cervical cancer.